|Assembly Actions - Lowercase
Senate Actions - UPPERCASE
|Jun 09, 2021||returned to senate|
|Jun 02, 2021||ordered to third reading rules cal.295|
substituted for a1921
|Mar 04, 2021||referred to higher education|
delivered to assembly
|Jan 25, 2021||advanced to third reading|
|Jan 20, 2021||2nd report cal.|
|Jan 19, 2021||1st report cal.95|
|Jan 12, 2021||referred to higher education|
senate Bill S1519
Current Bill Status - Passed Senate & Assembly
- In Committee
- On Floor Calendar
- Passed Senate
- Passed Assembly
- Delivered to Governor
- Signed/Vetoed by Governor
S1519 (ACTIVE) - Details
S1519 (ACTIVE) - Sponsor Memo
BILL NUMBER: S1519 SPONSOR: BAILEY TITLE OF BILL: An act to amend the education law, in relation to the use of oral medi- cations by optometrists PURPOSE OR GENERAL IDEA OF BILL: To authorize licensed optometrists! who receive certification to prescribe certain oral medications. SUMMARY OF SPECIFIC PROVISIONS: Sections one and two amend paragraphs (e) and (f) of subdivision 1 of section 7101-a of the education law, as added by chapter 517 of the laws of 1995, to clarify the use of certain topical therapeutic pharmaceu- tical agents which are already authorized for us6 by optometrists and are the standard of care in the treatment of patients for certain eye conditions.
S1519 (ACTIVE) - Bill Text download pdf
S T A T E O F N E W Y O R K ________________________________________________________________________ 1519 2021-2022 Regular Sessions I N S E N A T E January 12, 2021 ___________ Introduced by Sen. BAILEY -- read twice and ordered printed, and when printed to be committed to the Committee on Higher Education AN ACT to amend the education law, in relation to the use of oral medi- cations by optometrists THE PEOPLE OF THE STATE OF NEW YORK, REPRESENTED IN SENATE AND ASSEM- BLY, DO ENACT AS FOLLOWS: Section 1. Paragraph (e) of subdivision 1 of section 7101-a of the education law, as added by chapter 517 of the laws of 1995, is amended to read as follows: (e) [Phase one] TOPICAL therapeutic pharmaceutical agents. [Phase one] TOPICAL THERAPEUTIC pharmaceutical agents shall mean those drugs which shall be limited to topical application to the surface of the eye for therapeutic purposes and shall be limited to: (i) antibiotic/antimicrobials; (ii) decongestants/anti-allergenics; (iii) non-steroidal anti-inflammatory agents; (iv) steroidal anti-inflammatory agents; (v) antiviral agents; (vi) hyperosmotic/hypertonic agents; (vii) cycloplegics; (viii) artificial tears and lubricants; AND (IX) IMMUNOSUPPRESSIVE AGENTS. § 2. Paragraph (f) of subdivision 1 of section 7101-a of the education law, as added by chapter 517 of the laws of 1995, is amended to read as follows: (f) [Phase two therapeutic] THERAPEUTIC pharmaceutical agents FOR TREATMENT OF GLAUCOMA AND OCULAR HYPERTENSION. [Phase two] THERAPEUTIC pharmaceutical agents FOR TREATMENT OF GLAUCOMA AND OCULAR HYPERTENSION shall mean those drugs which shall be limited to topical application to the surface of the eye and shall be limited to: (i) beta blockers; EXPLANATION--Matter in ITALICS (underscored) is new; matter in brackets [ ] is old law to be omitted.
Open Legislation comments facilitate discussion of New York State legislation. All comments are subject to moderation. Comments deemed off-topic, commercial, campaign-related, self-promotional; or that contain profanity or hate speech; or that link to sites outside of the nysenate.gov domain are not permitted, and will not be published. Comment moderation is generally performed Monday through Friday.
By contributing or voting you agree to the Terms of Participation and verify you are over 13.